You have 9 free searches left this month | for more free features.

penicillamine

Showing 1 - 25 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head Neck Cancer, Recurrent Cancer Trial in Guangzhou (Penicillamine)

Not yet recruiting
  • Head and Neck Cancer
  • Recurrent Cancer
  • Penicillamine
  • Guangzhou, Guangdong, China
    Southern medical university
Oct 24, 2023

Cystinuria Trial in New York (Tiopronin 1g per day, Tiopronin 2g per day, Tiopronin 3g per day)

Completed
  • Cystinuria
  • Tiopronin 1g per day
  • +2 more
  • New York, New York
    NYU Langone Medical Center
Jul 28, 2021

Real World Evidence Study in Subjects With Wilson's Disease

Not yet recruiting
  • Wilson Disease
  • NCC-Sp Assay
  • (no location specified)
Mar 23, 2023

Wilson's Disease Trial in Hangzhou (DMPS, Penicillamine, DMSA)

Recruiting
  • Wilson's Disease
  • Hangzhou, Zhejiang, China
    econd Affiliated Hospital,Zhejiang University School of Medicine
May 19, 2019

Wilson's Disease Trial in Paris

Recruiting
  • Wilson's Disease
    • Leuven, Belgium
    • +13 more
    Jan 9, 2023

    Sun Damaged Skin Trial in Sacramento (Zinc Oxide and Avobenzone)

    Completed
    • Sun Damaged Skin
    • Zinc Oxide and Avobenzone
    • Sacramento, California
      University of California, Davis
    May 9, 2023

    Wilson Disease Trial in Worldwide (ALXN1840, Standard of Care)

    Recruiting
    • Wilson Disease
    • Parkville, Australia
    • +18 more
    Jun 3, 2022

    Wilson Disease Trial in Worldwide (Bis-Choline Tetrathiomolybdate)

    Active, not recruiting
    • Wilson Disease
    • Bis-Choline Tetrathiomolybdate
    • Sacramento, California
    • +10 more
    Jan 26, 2023

    Wilson Disease Trial in Worldwide (ALXN1840, SoC Therapy)

    Active, not recruiting
    • Wilson Disease
    • Los Angeles, California
    • +53 more
    May 2, 2022

    After Changing Medication From Nonselective to Selective

    Not yet recruiting
    • Eisenmenger Complex
      • (no location specified)
      Jan 26, 2021

      Copper Parameters in Wilson Disease Participants on Standard of

      Completed
      • Wilson Disease
      • Standard of Care Medications
      • New Haven, Connecticut
      • +9 more
      Nov 16, 2020

      Wilson Disease Trial in New Haven (Once a day Trientine)

      Completed
      • Wilson Disease
      • Once a day Trientine
      • New Haven, Connecticut
        Yale University
      Apr 1, 2020

      Wilson Disease Trial in Worldwide (trientine diHCl)

      Unknown status
      • Wilson Disease
      • trientine dihydrochloride
      • Heidelberg, Germany
      • +3 more
      Aug 22, 2017

      Ovarian Tumors Malignant (Excl Germ Cell), Peritoneal Carcinoma, Fallopian Tube Cancer Trial (trientine diHCl, pegylated

      Completed
      • Ovarian Neoplasms Malignant (Excl Germ Cell)
      • +2 more
      • trientine dihydrochloride
      • +2 more
      • (no location specified)
      Oct 18, 2020

      Arteriovenous Fistula Occlusion Trial in Chattanooga (Placebo, Ascorbic Acid, Cuprimine Oral Product)

      Unknown status
      • Arteriovenous Fistula Occlusion
      • Placebo
      • +2 more
      • Chattanooga, Tennessee
        Southeast Renal Research Institute
      Sep 6, 2017

      Wilson's Disease Trial (NPC-02)

      Completed
      • Wilson's Disease
      • (no location specified)
      Apr 14, 2019

      Cystine Capacity Clinical Study (CysCap)

      Completed
      • Cystinuria
        • New York, New York
          NYU Langone Medical Center
        Nov 29, 2018

        Myofascial Pain, Temporomandibular Disorder Trial in Ankara (Occlusal Splint, Botulinum toxin type A)

        Completed
        • Myofascial Pain
        • Temporomandibular Disorder
        • Occlusal Splint
        • Botulinum toxin type A
        • Ankara, Turkey
          Ankara University, Faculty of Dentistry
        Mar 25, 2019

        Systemic Sclerosis, Scleroderma Trial in Philadelphia (Ambrisentan)

        Completed
        • Systemic Sclerosis
        • Scleroderma
        • Philadelphia, Pennsylvania
          University of Pennsylvania Health System
        Nov 26, 2018

        Among Patients Initiating Xeljanz in Combination With Oral MTX

        Completed
        • Rheumatoid Arthritis
          • New York, New York
            Pfizer
          Sep 28, 2019

          Lead Poisoning, Vitamin D Deficiency Trial in Boston (d-penicillamine, )

          Withdrawn
          • Lead Poisoning
          • Vitamin D Deficiency
          • d-penicillamine
          • placebo
          • Boston, Massachusetts
            Children's Hospital Boston
          Mar 24, 2015

          Use of Biologics in Monotherapy for Treatment of Rheumatoid

          Completed
          • Rheumatoid Arthritis
            • Abergavenny, United Kingdom
            • +25 more
            Nov 1, 2016

            MabThera/Rituxan and Alternative TNF-Inhibitors in Rheumatoid

            Completed
            • Rheumatoid Arthritis
              • Winnipeg, Manitoba, Canada
              • +214 more
              Nov 28, 2016

              Systemic Sclerosis Trial in London (Fibrogammin®P, coagulation factor XIII concentrate (Human), 0.9% sodium chloride)

              Unknown status
              • Systemic Sclerosis
              • Fibrogammin®P, coagulation factor XIII concentrate (Human)
              • 0.9% sodium chloride
              • London, United Kingdom
                Royal Free London NHS Foundation Trust
              May 27, 2016